Latest News
Displaying 1 through 11 of 45 Next Page >>
| Multicenter TIF Registry Expanded to Nine Sites |
| JuLY 28, 2010 |
| Redwood City, CA (JuLY 28, 2010) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that it has added three sites and four investigators to its TIF (Transoral Incisionless Fundoplication) Registry Study. |
| EndoGastric Solutions Announces Appointment of Vice President of U.S. Sales |
| June 21, 2010 |
| Redwood City, CA (June 21, 2010) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), announced today that Mr. Christopher Marrus has joined the company as Vice President of U.S. Sales to continue the company’s rapid commercial growth and expansion. |
| EndoGastric Solutions Announces Launch of TIF Registry |
| May 10, 2010 |
| Redwood City, CA (April 28, 2010) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced the launch of the TIF (Transoral Incisionless Fundoplication) Registry Study. |
| First U.S. TIF2 Clinical Outcomes Data Presented at SAGES |
| April 28, 2010 |
| Redwood City, CA (April 28, 2010) — EndoGastric Solutions (EGS) today announced that new U.S. clinical results for their third generation Transoral Incisionless Fundoplication (TIF2) procedure were presented during the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting April 14-17, in Washington, DC. Clinical outcomes data for over 100 patients |
| 3,500th Natural Orifice Surgery Procedure Performed at Advanced CME Course on TIF |
| February 17, 2010 |
| Redwood City, CA (February 17, 2010) — EndoGastric Solutions (EGS), the leader in the emerging field of Natural Orifice Surgery (NOS), today reported that the 3,500th Natural Orifice Surgery (NOS) procedure was performed in front of the over 110 surgeons from seven countries attending the first Advanced Techniques in Transoral Fundoplication CME course, held |
| EGS Reports Extension of Clinical Evidence Supporting TIF |
| January 8, 2010 |
| Redwood City, CA (January 8, 2010) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that data from two single-center series demonstrate improved clinical outcomes from a third-generation technique for its Transoral Incisionless Fundoplication (TIF) procedure. This data includes two case series |
| EGS Announces Key Patent Issued |
| December 31 , 2009 |
| Redwood City, CA (December 31, 2009) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the U.S. Patent and Trademark Office has issued a key patent covering its SerosaFuse fastener and “over the wire” delivery system. Patent no. 7,632,287, entitled "Tissue fixation devices and assemblies |
| EGS Announces Advanced Transoral Fundoplication Educational Course Initiative for 2010 |
| December 9 , 2009 |
| Redwood City, CA (December 9, 2009) — EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced the Advanced Techniques in Transoral Fundoplication CME course series for 2010. The first course, scheduled for January 28-29, 2010, in Denver, CO, will be directed by esteemed surgeons Reginald Bell, MD |
| EGS Announces Additional Financial Investment |
| November 25, 2009 |
| Redwood City, CA (November 25, 2009) — EndoGastric Solutions (EGS) today announced the closing of a $21.5 Million Series E financing. The funding will be used to support an expanding commercial presence for the company’s market-leading Natural Orifice Surgery (NOS) platform, which includes the EsophyX and StomaphyX surgical devices. |
| EGS Announces Initiation of Clinical Study to Demonstrate Efficacy of StomaphyX for Revisional Weight Loss Surgery |
| Monday, August 24, 2009 |
| Redwood City, CA (August 24, 2009) — EndoGastric Solutions (EGS), the recognized leader in the field of Natural Orifice Surgery (NOS), announced enrollment of the first patients in a clinical trial evaluating the use of StomaphyX to reduce weight regain in patients who have had Roux-en-Y gastric bypass surgery. The StomaphyX clinical study |
| ASGS Issues Position Statement Supporting TIF Natural Orifice Surgery for GERD |
| Thursday, July 9, 2009 |
| Redwood City, CA (July 9, 2009) – EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), announced that the American Society of General Surgeons (ASGS) has published a position statement endorsing its Transoral Incisionless Fundoplication (TIF) procedure for the treatment of GERD. ASGS is the preeminent |
NP01937-01A
